Caitriona M. O'Driscoll

School of Pharmacy University College Cork, Cork, County Cork, Ireland 
"Caitriona O'Driscoll"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Bennett-Lenane H, O'Shea JP, O'Driscoll CM, et al. (2020) A Retrospective Biopharmaceutical Analysis of >800 Approved Oral Drug Products: Are Drug Properties of Solid Dispersions and Lipid-Based Formulations Distinctive? Journal of Pharmaceutical Sciences
Hibbitts A, O'Connor AM, McCarthy J, et al. (2019) Poly(ethylene glycol)-Based Peptidomimetic "PEGtide" of Oligo-Arginine Allows for Efficient siRNA Transfection and Gene Inhibition. Acs Omega. 4: 10078-10088
Singh RP, Hidalgo T, Cazade PA, et al. (2019) Self-assembled cationic β-cyclodextrin nanostructures for siRNA delivery. Molecular Pharmaceutics
O'Shea JP, Holm R, O'Driscoll CM, et al. (2018) Food for thought: formulating away the food effect - a PEARRL review. The Journal of Pharmacy and Pharmacology
Malhotra M, Gooding M, Evans JC, et al. (2018) Cyclodextrin-siRNA conjugates as versatile gene silencing agents. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 114: 30-37
Evans JC, Malhotra M, Sweeney K, et al. (2017) Folate-targeted amphiphilic cyclodextrin nanoparticles incorporating a fusogenic peptide deliver therapeutic siRNA and inhibit the invasive capacity of 3D prostate cancer tumours. International Journal of Pharmaceutics
Guo J, Schlich M, Cryan JF, et al. (2017) Targeted drug delivery via folate receptors for the treatment of brain cancer: Can the promise deliver? Journal of Pharmaceutical Sciences
O'Shea JP, Nagarsekar K, Wieber A, et al. (2017) Mesoporous silica-based dosage forms improve bioavailability of poorly soluble drugs in pigs: case example fenofibrate. The Journal of Pharmacy and Pharmacology
Guo J, Russell EG, Darcy R, et al. (2017) Antibody-targeted cyclodextrin-based nanoparticles for siRNA delivery in the treatment of acute myeloid leukaemia - physicochemical characteristics, in vitro mechanistic studies and ex vivo patient derived therapeutic efficacy. Molecular Pharmaceutics
Evans JC, Malhotra M, Fitzgerald KA, et al. (2017) Formulation and Evaluation of Anisamide-Targeted Amphiphilic Cyclodextrin Nanoparticles To Promote Therapeutic Gene Silencing in a 3D Prostate Cancer Bone Metastases Model. Molecular Pharmaceutics. 14: 42-52
See more...